Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Luke EvninDirector | Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 06/29 | 06/29 | 157,084 sh | $0.30 | $47,125.2 | −52.3% |
Werewolf TherapeuticsHOWL | Open-market sale | 06/17 | 06/22 | 416,911 sh2 trades | $0.35avg. | $145,918.85 | −57.9% | |
Werewolf TherapeuticsHOWL | Open-market sale | 06/12–06/16 | 06/16 | 448,836 sh6 trades | $0.39avg. | $173,757.95 | −57.5% | |
Werewolf TherapeuticsHOWL | Open-market sale | 06/09–06/11 | 06/11 | 678,226 sh6 trades | $0.37avg. | $253,568.65 | −65.2% | |
Luke EvninDirector | Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 06/09 | 06/10 | 76,928 sh | $0.37 | $28,463.36 | −20.4% |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 06/04–06/08 | 06/08 | 105,565 sh3 trades | $0.41avg. | $43,028.88 | −21.9% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 06/01–06/03 | 06/03 | 139,803 sh3 trades | $0.46avg. | $63,628.06 | −22.5% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 05/27–05/29 | 05/29 | 141,106 sh3 trades | $0.47avg. | $66,200.24 | −18.5% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 05/21–05/26 | 05/26 | 191,762 sh3 trades | $0.45avg. | $86,560.29 | −20.1% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 05/18–05/20 | 05/20 | 171,049 sh3 trades | $0.45avg. | $76,363.35 | −15.2% | |
Luke EvninDirector | Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 05/13 | 05/13 | 44,679 sh | $0.54 | $24,126.66 | −3.8% |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 05/08–05/12 | 05/12 | 407,574 sh3 trades | $0.69avg. | $280,210.26 | −25.8% | |
Werewolf TherapeuticsHOWL | Open-market sale | 05/08–05/12 | 05/12 | 565,167 sh6 trades | $0.69avg. | $390,688.4 | −58.2% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 05/05–05/07 | 05/07 | 100,581 sh3 trades | $0.64avg. | $64,216.68 | −6.0% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 04/30–05/04 | 05/04 | 274,619 sh3 trades | $0.72avg. | $198,309.62 | −14.1% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 04/27–04/29 | 04/29 | 205,911 sh3 trades | $0.75avg. | $154,525.47 | −9.5% | |
Luke EvninDirector | Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 01/16 | 01/20 | 38,782 sh | $0.54 | $20,942.28 | −1.8% |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 01/13–01/15 | 01/15 | 111,227 sh3 trades | $0.56avg. | $61,787.17 | −4.8% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 01/08–01/12 | 01/12 | 91,374 sh3 trades | $0.59avg. | $53,533.26 | −3.8% | |
Werewolf TherapeuticsHOWL | Open-market sale10b5-1 plan | 01/05–01/07 | 01/07 | 71,054 sh3 trades | $0.65avg. | $45,882.17 | −2.9% |